Technology ❯Biotechnology

Vaccine Technology

Vaccine Technology Vaccines Department of Health and Human Services Public Health Coronaviruses Vaccine Development Immunology Vaccine Controversy Cancer Cell Biology

HHS Ends $600 Million Moderna Deal for H5N1 Vaccine Development

Health Secretary Robert F. Kennedy Jr.’s mistrust of mRNA platforms prompted the decision despite promising Phase 1/2 data for the H5N1 project.

New mRNA Vaccine Strategy Boosts Long-Lasting Immune Memory in Preclinical Study

HHS and NIH Launch $500 Million Universal Vaccine Initiative Using Whole-Virus Approach